Stay updated on Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.

Latest updates to the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%
- Check16 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has updated its facility name and location details, specifically highlighting St. Louis, Missouri, and added drug information for Pegvaliase, while removing some previous location terms and outdated genetic disease information.SummaryDifference2%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Pegvaliase Self-Injection PKU Clinical Trial page.